Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51:1206-12. https://doi.org/10.1111/j.1365-4632.2011.05377.x

Sehgal VN, Srivastava G. Vitiligo: Compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149-56. https://doi.org/10.4103/0378-6323.32708

Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386:74-84. https://doi.org/10.1016/S0140-6736(14)60763-7

Taieb A, Morice-Picard F, Jouary T, Ezzedine K, et al. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: Implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 2008;21:646-52. https://doi.org/10.1111/j.1755-148X.2008.00511.x

Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014;27:134-9. https://doi.org/10.1111/pcmr.12186

Xianfeng C, Yuegen J, Zhiyu Y, Yan Y, Xuesi Z, Fenglai W, et al. Pediatric patients with vitiligo in eastern China: Abnormalities in 145 cases based on thyroid function tests and Immunological findings. Med Sci Monit. 2015;21:3216-21. https://doi.org/10.12659/MSM.894981

Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53:220-3. https://doi.org/10.1016/j.jaad.2005.03.032

Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, et al. Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne). 2017;27:290. https://doi.org/10.3389/fendo.2017.00290

Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngol Head Neck Surg. 2010;142:409-14. https://doi.org/10.1016/j.otohns.2009.11.007

Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC, et al. Comorbidity profiles in association with vitiligo: A nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015;29:1362-9. https://doi.org/10.1111/jdv.12870

Sharma CK, Sharma M, Prasad K. Involvement of different genes expressions during immunological and inflammatory responses in vitiligo.Crit Rev Eukaryot Gene Expr. 2017;27:277-87. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2017019558

Spritz RA, Andersen GH. Genetics of vitiligo.Dermatol Clin. 2017;35:245-55. https://doi.org/10.1016/j.det.2016.11.013

Dammak I, Boudaya S, Ben Abdallah F, Turki H, Attia H, Hentati B. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol. 2009;48:476-80. https://doi.org/10.1111/j.1365-4632.2009.03998.x

Speeckaert R, van Geel N. Vitiligo: An update on pathophysiology and treatment options. Am J Clin Dermatol. 2017;18:733-44. https://doi.org/10.1007/s40257-017-0298-5

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1-13. https://doi.org/10.1016/j.jaad.2016.10.048

Elela MA, Hegazy RA, Fawzy MM, Rashed LA, Rasheed H. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: A case-controlled study on eighty-four patients. Eur J Dermatol. 2013;23:350-5. https://doi.org/10.1684/ejd.2013.2023

Chatterjee S, Eby JM, Al-Khami AA, Soloshchenko M, Kang HK, Kaur N, et al. A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014;134:1285-94 https://doi.org/10.1038/jid.2013.540

Dong J, An X, Zhong H, Wang Y, Shang J, Zhou J. Oncotarget. 2017;8:109161-74. https://doi.org/10.18632/oncotarget.22644

Barygina V, Becatti M, Lotti T, Moretti S, Taddei N, Fiorillo C. Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci. 2015;79:163-70. https://doi.org/10.1016/j.jdermsci.2015.05.003

Lotti T, Hercogova J, Wollina U, Chokoeva AA, Zarrab Z, Gianfaldoni S, et al. Vitiligo: Successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents. 2015;29(Suppl.):53-8.

Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1-13. https://doi.org/10.1111/j.1755-148X.2012.00997.x

van Geel N, De Lille S, Vandenhaute S, Gauthier Y, Mollet I, Brochez L, et al. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol. 2011;25:673-8. https://doi.org/10.1111/j.1468-3083.2010.03847.x

Silverberg NB. Pediatric vitiligo. Pediatr Clin North Am. 2014;61:347-66. https://doi.org/10.1016/j.pcl.2013.11.008

Prcic S, Djuran V, Katanic D, Vlaski J, Gajinov Z. Vitiligo and thyroid dysfunction in children and adolescents. Acta Dermatovenerol Croat. 2011;19:248- 54.

Weyant GW, Chung CG, Helm KF. Halo nevus: Review of the literature and clinicopathologic findings. Int J Dermatol. 2015;54:433-5. https://doi.org/10.1111/ijd.12843

Zhou H, Wu LC, Chen MK, Liao QM, Mao RX, Han JD. Factors associated with development of vitiligo in patients with halo nevus. Chin Med J (Engl). 2017:20;130:2703-8. https://doi.org/10.4103/0366-6999.218011

Diaz-Angulo S, López-Hoyos M, Muñoz-Cacho P, López-Escobar M, González-López MA. High prevalence of thyroid autoimmunity in patients with alopecia areata and vitiligo: A controlled study. Australas J Dermatol. 2015;56:142-3. https://doi.org/10.1111/ajd.12321

Anbar TS, El-Badry MM, McGrath JA, Abdel-Azim ES. Most individuals with either segmental or nonsegmental vitiligo display evidence of bilateral cochlear dysfunction. Br J Dermatol. 2015;172:406-11. https://doi.org/10.1111/bjd.13276

Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010;62:937-41. https://doi.org/10.1016/j.jaad.2009.11.024

Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014;32:524-30. https://doi.org/10.1016/j.clindermatol.2014.02.006

Amer AA, Mchepange UO, Gao XH, Hong Y, Qi R, Wu Y, et al. Hidden victims of childhood vitiligo: Impact on parents' mental health and quality of life. Acta Derm Venereol. 2015;95:322-5. https://doi.org/10.2340/00015555-1940

Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31:309-18. https://doi.org/10.1111/pde.12226

Sánchez G, Araluce M. Vitiligo: aspectos psicológicos. Rev Hosp Psiquiatr Habana. 1988;29:463-76.

Cupertino F, Niemeyer-Corbellini JP, Ramos-ESilva M. Psychosomatic aspects of vitiligo. Clin Dermatol. 2017;35:292-7. https://doi.org/10.1016/j.clindermatol.2017.01.001

van Driessche F, Silverberg N. Current management of pediatric vitiligo. Paediatr Drugs. 2015;17:303-13. https://doi.org/10.1007/s40272-015-0135-3

Taieb A, Alomar A, Bohm M, Dell'anna ML, De Pase A, Eleftheriadou V, et al. Guidelines for the management of vitiligo: The European Dermatology Forum consensus. Br J Dermatol. 2013;168:5- 19. https://doi.org/10.1111/j.1365-2133.2012.11197.x

de Menezes AF, Oliveira de Carvalho F, Barreto RS, de Santana Silva B, Shanmugam S, Gurgel RQ, et al. Pharmacologic treatment of vitiligo in children and adolescents: A systematic review. Pediatr Dermatol. 2017;34:13-24. https://doi.org/10.1111/pde.13024

Kose O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat. 2010;21:133-9. https://doi.org/10.3109/09546630903266761

Kwon HB, Choi Y, Kim HJ, Lee AY. The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: A placebo-controlled, paired-comparison, left-right study. J Drugs Dermatol 2013;12:63-7.

Parsad D, Saini R, Juneja A. Combination of clobetasol and tretinoin in vitiligo. Int J Dermatol. 2000;39:639-40.

Coskun B, Saral Y, Turgut D. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. Eur J Dermatol. 2005;15:88-91.

Wong R, Lin AN. Efficacy of topical calcineurin inhibitors in vitiligo. Int J Dermatol. 2013;52:491-6. https://doi.org/10.1111/j.1365-4632.2012.05697.x

Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases. J Am Acad Dermatol. 2004;51:760-6. https://doi.org/10.1016/j.jaad.2004.05.036

Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47:789-91. https://doi.org/10.1067/mjd.2002.126250

Li R, Qiao M, Wang X, Zhao X, Sun Q . Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: A meta-analysis. Photodermatol Photoimmunol Photomed. 2017;33:22-31. https://doi.org/10.1111/phpp.12277

Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res. 2004;24:11-4.

Vásquez-López F, López-Escobar M, Pérez-Oliva N. Calcipotriene and vitiligo. Arch Dermatol. 2003;139:1656-7. https://doi.org/10.1001/archderm.139.12.1656

Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: A preliminary study. Pediatr Dermatol. 1999;16:317-20. https://doi.org/10.1046/j.1525-1470.1999.00083.x

Majid I, Imran S. Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: A 12-month follow-up study. Indian J Dermatol. 2013;58:113-6. https://doi.org/10.4103/0019-5154.108040

Majid I, Masood Q, Hassan I, Khan D, Chisti M. Childhood vitiligo: Response to methylprednisolone oral minipulse therapy and topical fluticasone combination. Indian J Dermatol. 2009;54:124-7. https://doi.org/10.4103/0019-5154.53185

Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30:332-6. https://doi.org/10.1111/j.1365-2230.2005.01837.x

Koh MJ, Mok ZR, Chong WS. Phototherapy for the treatment of vitiligo in Asian children. Pediatr Dermatol. 2015;32:192-7. https://doi.org/10.1111/pde.12506

Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245-53. https://doi.org/10.1016/S0190-9622(00)90133-6

Gianfaldoni S, Tchernev G, Wollina U, Lotti J, Rovesti M, Satolli F, et al. Vitiligo in children: What's new in treatment? Open Access Maced J Med Sci. 2018;6:221-5. https://doi.org/10.3889/oamjms.2018.060

Bae JM, Yoo HJ, Kim H, Lee JH, Kim GM. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients. J Am Acad Dermatol. 2015;73:76-82. https://doi.org/10.1016/j.jaad.2015.04.008

Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong-Rong L. Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Pediatr Dermatol. 2009;26:354-6. https://doi.org/10.1111/j.1525-1470.2009.00914.x

Saraceno R, Nistico SP, Capriotti E, Chimenti S. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: A controlled study. Dermatol Ther. 2009;22:391-4. https://doi.org/10.1111/j.1529-8019.2009.01252.x

Ostovari N, Passeron T, Zakaria W, Fontas E, Larouy JC, Blot JF. Treatment of vitiligo by 308-nm excimer laser: An evaluation of variables affecting treatment response. Lasers Surg Med. 2004;35:152-6. https://doi.org/10.1002/lsm.20057

Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, et al. Phototherapy for Vitiligo: A systematic review and meta-analysis. JAMA Dermatol. 2017;153:666-74. https://doi.org/10.1001/jamadermatol.2017.0002

Calzavara-Pinton PG, Ortel B, Carlino AM, Honigsmann H, De Panfilis G. Phototesting and phototoxic side effects in bath PUVA. J Am Acad Dermatol. 1993;28:657-9. https://doi.org/10.1016/S0190-9622(08)81791-4

Koulu LM, Jansén CT. Skin phototoxicity variations during repeated bath PUVA exposures to 8-methoxypsoralen and trimethylpsoralen. Clin Exp Dermatol. 1984;9:64-9. https://doi.org/10.1111/j.1365-2230.1984.tb00757.x

Valkova S, Trashlieva M, Christova P. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol. 2004;29:180-4. https://doi.org/10.1111/j.1365-2230.2004.01462.x

Carlie G, Ntusi NB, Hulley PA, Kidson SH. KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. Br J Dermatol. 2003;149:707-17. https://doi.org/10.1046/j.1365-2133.2003.05577.x

Camacho F, Mazuecos J. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo. J Drugs Dermatol. 2002;1:127-31.

Camacho F, Mazuecos J. Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. Arch Dermatol. 1999;135:216-7. https://doi.org/10.1001/archderm.135.2.216

Matin R. Vitiligo in adults and children: Surgical interventions. BMJ Clin Evid. 2015:20;2015.

Mulekar SV, Isedeh P. Surgical interventions for vitiligo: An evidence-based review. Br J Dermatol. 2013;169:57-66. https://doi.org/10.1111/bjd.12532

Lahiri K. Evolution and evaluation of autologous mini punch grafting in vitiligo. Indian J Dermatol. 2009;54:159-67. https://doi.org/10.4103/0019-5154.53195

Dillon AB, Sideris A, Hadi A, Elbuluk N. Advances in vitiligo: An update on medical and surgical treatments. J Clin Aesthet Dermatol. 2017;10:15-28.

Falabella R. The minigrafting test for vitiligo: Validation of a predicting tool. J J Am Acad Dermatol. 2004;51:672-3. https://doi.org/10.1016/j.jaad.2003.11.085

Falabella R. Treatment of localized vitiligo by autologous minigrafting. Arch Dermatol. 1988;124:1649-55. https://doi.org/10.1001/archderm.1988.01670110009002